Retinal Dystrophies Associated With Peripherin-2: Genetic Spectrum and Novel Clinical Observations in 241 Patients.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 May 2024
Historique:
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: ppublish

Résumé

To describe the clinical, electrophysiological and genetic spectrum of inherited retinal diseases associated with variants in the PRPH2 gene. A total of 241 patients from 168 families across 15 sites in 9 countries with pathogenic or likely pathogenic variants in PRPH2 were included. Records were reviewed for age at symptom onset, visual acuity, full-field ERG, fundus colour photography, fundus autofluorescence (FAF), and SD-OCT. Images were graded into six phenotypes. Statistical analyses were performed to determine genotype-phenotype correlations. The median age at symptom onset was 40 years (range, 4-78 years). FAF phenotypes included normal (5%), butterfly pattern dystrophy, or vitelliform macular dystrophy (11%), central areolar choroidal dystrophy (28%), pseudo-Stargardt pattern dystrophy (41%), and retinitis pigmentosa (25%). Symptom onset was earlier in retinitis pigmentosa as compared with pseudo-Stargardt pattern dystrophy (34 vs 44 years; P = 0.004). The median visual acuity was 0.18 logMAR (interquartile range, 0-0.54 logMAR) and 0.18 logMAR (interquartile range 0-0.42 logMAR) in the right and left eyes, respectively. ERG showed a significantly reduced amplitude across all components (P < 0.001) and a peak time delay in the light-adapted 30-Hz flicker and single-flash b-wave (P < 0.001). Twenty-two variants were novel. The central areolar choroidal dystrophy phenotype was associated with 13 missense variants. The remaining variants showed marked phenotypic variability. We described six distinct FAF phenotypes associated with variants in the PRPH2 gene. One FAF phenotype may have multiple ERG phenotypes, demonstrating a discordance between structure and function. Given the vast spectrum of PRPH2 disease our findings are useful for future clinical trials.

Identifiants

pubmed: 38743414
pii: 2793659
doi: 10.1167/iovs.65.5.22
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

22

Auteurs

Rachael C Heath Jeffery (RC)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia.
Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.

Jennifer A Thompson (JA)

Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Johnny Lo (J)

School of Science, Edith Cowan University, Perth, Western Australia, Australia.

Enid S Chelva (ES)

Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Sean Armstrong (S)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Jose S Pulido (JS)

Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, United States.

Rebecca Procopio (R)

Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, United States.

Andrea L Vincent (AL)

Department of Ophthalmology, FMHS, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.
Eye Department, Greenlane Clinical Centre, Auckland District Health Board, Auckland, New Zealand.

Lorenzo Bianco (L)

Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Maurizio Battaglia Parodi (M)

Department of Ophthalmology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lucia Ziccardi (L)

IRCCS-Fondazione Bietti, Rome, Italy.

Giulio Antonelli (G)

IRCCS-Fondazione Bietti, Rome, Italy.

Lucilla Barbano (L)

IRCCS-Fondazione Bietti, Rome, Italy.

João P Marques (JP)

Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Clinical and Academic Centre of Coimbra (CACC), Coimbra, Portugal.

Sara Geada (S)

Ophthalmology Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Clinical and Academic Centre of Coimbra (CACC), Coimbra, Portugal.

Ana L Carvalho (AL)

Medical Genetics Unit, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal.

Wei C Tang (WC)

Singapore National Eye Centre, Singapore, Singapore.
Singapore Eye Research Institute, Singapore, Singapore.

Choi M Chan (CM)

Singapore National Eye Centre, Singapore, Singapore.
Singapore Eye Research Institute, Singapore, Singapore.

Camiel J F Boon (CJF)

Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
Department of Ophthalmology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands.

Jonathan Hensman (J)

Department of Ophthalmology, Amsterdam University Medical Center, University of Amsterdam, the Netherlands.

Ta-Ching Chen (TC)

Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
Center of Frontier Medicine, National Taiwan University Hospital, Taipei, Taiwan.

Chien-Yu Lin (CY)

Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.

Pei-Lung Chen (PL)

Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.

Ajoy Vincent (A)

Department of Ophthalmology, Hospital for Sick Children, Toronto, Ontario, Canada.

Anupreet Tumber (A)

Department of Ophthalmology, Hospital for Sick Children, Toronto, Ontario, Canada.

Elise Heon (E)

Department of Ophthalmology, Hospital for Sick Children, Toronto, Ontario, Canada.

John R Grigg (JR)

Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Eye Genetics Research Unit, Children's Medical Research Institute, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Robyn V Jamieson (RV)

Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Eye Genetics Research Unit, Children's Medical Research Institute, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Elisa E Cornish (EE)

Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.

Benjamin M Nash (BM)

Eye Genetics Research Unit, Children's Medical Research Institute, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Sydney Genome Diagnostics, Western Sydney Genetics Program, Sydney Children's Hospitals Network, Sydney, New South Wales, Australia.

Shyamanga Borooah (S)

University of California San Diego, La Jolla, California.
The Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, CA, United States.

Lauren N Ayton (LN)

Department of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Alexis Ceecee Britten-Jones (AC)

Department of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Thomas L Edwards (TL)

Department of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Jonathan B Ruddle (JB)

Department of Optometry and Vision Sciences, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.

Abhishek Sharma (A)

Ophthalmology Department, Royal Brisbane and Women's Hospital, Brisbane, Australia.

Rowan G Porter (RG)

Southern Queensland Centre of Excellence, Inala, Australia.

Tina M Lamey (TM)

Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Terri L McLaren (TL)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

Samuel McLenachan (S)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.

Danial Roshandel (D)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.

Fred K Chen (FK)

Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Western Australia, Australia.
Ocular Tissue Engineering Laboratory, Lions Eye Institute, Nedlands, Western Australia, Australia.
Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
Australian Inherited Retinal Disease Registry and DNA Bank, Department of Medical Technology and Physics, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia.
Ophthalmology, Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH